Status | Study |
Recruiting |
Study Name: Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis. Condition: Polyoma Virus Infection Thyroiditis, Autoimmune Date: 2017-03-31 Interventions: Other: Comparison of Positive PCR Frequencies for Polyomavirus in Blood, Urine and / or Thyroid Tissue vs Basedow / Hashimoto |
Available |
Study Name: Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC) Condition: Metastatic Merkel Cell Carcinoma Date: 2017-03-20 Interventions: Drug: Avelumab Avelumab should be administered intravenously as per the recommended dose. Administration |
Recruiting |
Study Name: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Skin Cancer Date: 2017-03-01 Interventions: Drug: Nivolumab Nivolumab 240 |
Not yet recruiting |
Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condition: Adenoid Cystic Carcinoma Adnexal Carcinoma Apocrine Carcin Date: 2016-11-30 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers Condition: Neuroendocrine Tumors Carcinoma, Small Cell Lung Carcinoma Date: 2016-10-13 Interventions: Drug: PEN-221 Administration of PEN-221 once every three weeks |
Completed |
Study Name: Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy Condition: Progressive Multifocal Leukoencephalopathy Date: 2016-09-06 |
Recruiting |
Study Name: Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides Condition: Solid Tumors Mycosis Fungoides Melanoma Date: 2016-08-26 Interventions: Drug: TTI-621 TTI-621 (SIRPαFc) is a soluble recombinant fusion protein created by directly linking |
Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition: Functional Pancreatic Neuroendocrine Tumor Malignant Somatostatinoma Date: 2016-07-10 Interventions: Drug: Capecitabine Given PO |
Recruiting |
Study Name: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Polyomavirus Infection Stage IV Merkel Cell Carcino Date: 2015-10-21 Interventions: Drug: Avelumab Given IV |
Recruiting |
Study Name: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2015-07-28 Interventions: Drug: MLN0128 Investigational mTOR kinase inhibitor |